It was shown previously that the MVA pathway inhibitors simvastatin and ibandronate affect epigenetic regulation in cancer cells.35 We demonstrate here that the promoter region of IL‐33 comprises a more open chromatin structure in fluvastatin‐treated cardiac cells compared to untreated cells as analysed by promoter accessibility. The gene discussed is IL33; the disease is cancer.